» Articles » PMID: 3743961

Somatomedin-C Levels in Growth-impaired Children and Adolescents with Chronic Inflammatory Bowel Disease

Overview
Specialty Gastroenterology
Date 1986 Oct 1
PMID 3743961
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between caloric insufficiency and impaired growth in children with chronic inflammatory bowel disease has been increasingly recognized in recent years. The mechanism by which nutritional insufficiency leads to decreased growth in these children is unclear. Our study suggests that chronic undernutrition lowers circulating somatomedin-C, which is known to exert anabolic effects on peripheral tissues. Therapeutic intervention that increases caloric intake results in improved somatomedin-C levels and growth velocity. Monitoring somatomedin-C levels in growth-impaired children with inflammatory bowel disease provides an important marker of nutritional sufficiency and reversibility of growth retardation.

Citing Articles

Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis.

Witkowska-Sedek E, Pyrzak B Cent Eur J Immunol. 2021; 45(4):469-475.

PMID: 33613096 PMC: 7882400. DOI: 10.5114/ceji.2020.103422.


Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.

Soendergaard C, Young J, Kopchick J Int J Mol Sci. 2017; 18(5).

PMID: 28486400 PMC: 5454932. DOI: 10.3390/ijms18051019.


Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial.

Jones K, Hunten-Kirsch B, Laving A, Munyi C, Ngari M, Mikusa J BMC Med. 2014; 12:133.

PMID: 25189855 PMC: 4243388. DOI: 10.1186/s12916-014-0133-2.


IGF-1, the cross road of the nutritional, inflammatory and hormonal pathways to frailty.

Maggio M, De Vita F, Lauretani F, Butto V, Bondi G, Cattabiani C Nutrients. 2013; 5(10):4184-205.

PMID: 24152751 PMC: 3820068. DOI: 10.3390/nu5104184.


Mathematical modelling to restore circulating IGF-1 concentrations in children with Crohn's disease-induced growth failure: a pharmacokinetic study.

Rao A, Standing J, Naik S, Savage M, Sanderson I BMJ Open. 2013; 3(5).

PMID: 23793696 PMC: 3664353. DOI: 10.1136/bmjopen-2013-002737.